Injury to the spleen

Current Problems in Surgery

Volumn 38, Issue 12, 2001, Pages 932-1008

  Peitzman, Andrew B ^a   Ford, Henri R ^a   Harbrecht, Brian G ^a   Potoka, Douglas A ^a   Townsend, Ricard N ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFUROXIME; COTRIMOXAZOLE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMOSTATIC AGENT; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN G; PENICILLIN V; PNEUMOCOCCUS VACCINE;

ABDOMINAL BLUNT TRAUMA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOTRANSPLANTATION; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; HEMODYNAMICS; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LAPAROTOMY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATIENT SELECTION; PERITONEUM LAVAGE; POSTOPERATIVE INFECTION; SAFETY; SALVAGE THERAPY; SPLEEN ANGIOGRAPHY; SPLEEN FUNCTION; SPLEEN INJURY; SPLEEN SCINTISCANNING; SPLENECTOMY; TREATMENT FAILURE; VACCINATION;

EID: 0035736443     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/msg.2001.119121     Document Type: Article

References (229)

1. Is splenectomy harmless?
2. Webster's Third New International Dictionary
3. The spleen in the Talmud and other early Jewish writings
4. The Midrash
5. The importance of the spleen in resistance to infection
6. Perspectives in the management of trauma to the spleen: 1979 presidential address, AAST
7. Management of trauma to the spleen
8. Splenectomy and susceptibility to malaria and Babesia infection
9. Splenectomy
10. Ruptures de la rate
11. Delayed hemorrhage following traumatic rupture of the spleen
12. Splenectomy for trauma
13. Congenital idiopathic thrombopenic purpura in a premature infant with splenectomy
14. Splenic studies: I. Susceptibility to infection after splenectomy performed in infancy
15. Splenectomy in childhood and the hazard of overwhelming infection
16. Postsplenectomy sepsis
17. Bacterial infection and the asplenic host: A review
18. Tuftsin deficiency: A new syndrome with defective phagocytosis
19. Defective phagocytosis due to tuftsin deficiency in splenectomized subjects
20. Tuftsin deficiency syndrome. A report of two cases
21. Severe late postsplenectomy infection
22. Partial splenectomy technique and some hematologic consequences in the dog
23. Splenic trauma and overwhelming post-splenectomy infection
24. Impaired antipneumococcal antibody production in patients without spleens
25. Splenectomy in childhood: A review of 1413 cases
26. Fatal post-splenectomy sepsis despite prophylaxis with penicillin and pneumococcal vaccine
27. Postsplenectomy sepsis 10 years or more after operation
28. Poor protective effect of unregenerated splenic tissue to pneumococcal challenge after subtotal splenectomy
29. Late septic complications in adults following splenectomy for trauma: A prospective analysis in 144 patients
30. Dysgonic fermenter 2 septicemia
31. Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks
32. Opsonic requirements for intravascular clearance after splenectomy
33. Impaired immune response of splenectomized patients to polyvalent pneumococcal vaccine
34. Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity
35. The overwhelming postsplenectomy sepsis problem
36. Causes of death among patients surviving at least one year following splenectomy
37. Preservation of splenic tissue prevents postsplenectomy pulmonary sepsis following bacterial challenge
38. Immunobiological consequences of splenectomy: A review
39. Management of asplenic patients
40. Overwhelming postsplenectomy infection
41. Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma
42. Suppressor T cell activity in splenectomized subjects
43. Failure of splenic implants to protect against fatal postsplenectomy infection
44. 'Tuftsin': A natural phagocytosis stimulating peptide
45. The risk of sepsis in the asplenic adult
46. Splenic trauma
47. The effect of partial splenectomy on experimental pneumococcal bacteremia in an animal model
48. Postsplenectomy septic activity
49. Postsplenectomy complications
50. The born-again spleen: Return of splenic function after splenectomy for trauma
51. Injuries of the spleen
52. Incidence of septic and thromboembolic-related deaths after splenectomy in adults
53. Effect of splenectomy and hemisplenectomy on pneumococcal infection and bacteria clearance in the rat
54. The effect of splenectomy on the formation of circulating antibody in the adult male albino rat
55. The formation of circulating antibody in the splenectomized human being following intravenous injection of heterologous erythrocytes
56. Effects of splenectomy on the humoral immune system: A study in neonatal and adult splenectomized mice
57. Serum immunoglobulin and transferrin levels after childhood splenectomy
58. Postsplenectomy sepsis and mortality in adults
59. Septic sequelae after splenectomy for trauma in adults
60. Postsplenectomy sepsis
61. Rationale for and methods of splenic preservation following trauma
62. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens
63. Infections associated with asplenia: Risks, mechanisms, and prevention
64. Immune response after splenectomy
65. Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation
66. Humoral immunity in experimental hyposplenism
67. Critical splenic mass for survival from experimental pneumococcemia
68. A study of 42 episodes of overwhelming postsplenectomy infection: Is current guidance for asplenic individuals being followed?
69. Prevention of postsplenectomy sepsis
70. Splenectomy after blunt abdominal trauma: A retrospective study of 413 children
71. Splenectomy in childhood: A review in England and Wales, 1960-4
72. Pneumococcal serum opsonizing activity in splenectomized children
73. + T cells and impaired primary immune response after post-traumatic splenectomy
74. Rarity of failure of penicillin prophylaxis to prevent post-splenectomy sepsis
75. Serious infections in adults following splenectomy for trauma
76. Immunological studies in children before and after splenectomy
77. Fatal pneumococcal bacteremia in a vaccinated splenectomized child
78. Cellular immunity in splenectomized patients
79. Partial splenectomy and overwhelming infection in rats
80. Fatal post-splenectomy pneumococcal sepsis despite pneumococcal vaccine and penicillin prophylaxis
81. Efficacy of passive immunotherapy in experimental postsplenectomy sepsis due to Haemophilus influenzae type B
82. Properdin levels in splenectomized persons
83. Serum immunoglobin changes after accidental splenectomy in adults
84. Immunological studies in the postsplenectomy syndrome
85. Increased susceptibility of splenectomized mice to infection after exposure to an aerosolized suspension of type III Streptococcus pneumoniae
86. Pulmonary infection in splenectomized mice: Protection by splenic remnant
87. Injury to the spleen
88. Immunoglobulins and complement in splenectomized and autotransplanted subjects
89. Overwhelming postsplenectomy infection
90. Opsonin and leukophilic gamma-globulin in chronically splenectomized rats with and without heterotopic autotransplanted splenic tissue
91. Nonoperative observation for splenic injury: A safe therapeutic option?
92. Prospective validation of criteria including age for safe, nonsurgical management of the ruptured spleen
93. Management of injury to the spleen in adults: Results of early operation and observation
94. Statewide variation in the treatment of patients hospitalized with spleen injury
95. Alternatives to splenectomy in adults after trauma. Repair, partial resection, and reimplantation of splenic tissue
96. Risk of splenic salvage after trauma: Analysis of 200 adults
97. Techniques of splenic conservation
98. Let the preserver of spleens beware
99. Splenic regeneration and blood flow after ligation of the splenic artery or partial splenectomy
100. Changing patterns in the management of splenic trauma: The impact of nonoperative management
101. Experience with selective operative and nonoperative treatment of splenic injuries in 193 patients
102. Operative splenic salvage in adults: A decade perspective
103. A simplified approach to techniques of splenic salvage
104. Splenic trauma in children
105. Patient management guidelines for the non-operative management of blunt injury to the liver and spleen: EAST practice parameter workgroup for solid organ injury
106. Mobilization of the spleen in splenic salvage
107. Predictability of splenic salvage by computed tomography
108. Splenorrhaphy: Changing concepts for the traumatized spleen
109. Segmental resections of the spleen: Report on the first eight cases operated on
110. Relative merits of partial splenectomy, splenic reimplantation, and immunization in preventing postsplenectomy infection
111. The conservative management of splenic trauma
112. Wound healing of the injured spleen with and without splenorrhaphy
113. A four year experience with splenectomy versus splenorrhaphy
114. Splenorrhaphy: The alternative
115. Protective effect of residual splenic tissue after subtotal splenectomy
116. Nonoperative management of traumatized spleen in children: How and why
117. Scintigraphy in the follow-up of pediatric splenic trauma treated without surgery
118. Nonoperative management of the adult ruptured spleen
119. Splenic injury: Trends in evaluation and management
120. Management outcomes in splenic injury: A statewide trauma center review
121. Nonoperative management of blunt splenic trauma: A multicenter experience
122. Management and outcome of splenic injury: The result of a five-year statewide population-based study
123. Nonoperative management of blunt hepatic and splenic injury in children
124. Blunt splenic trauma: Characteristics of patients requiring urgent laparotomy
125. Delayed complications of nonoperative management of blunt splenic trauma
126. Improved success in nonoperative management of blunt splenic injuries: Embolization of splenic artery pseudoaneurysms
127. Predicting clinical outcome of nonsurgical management of blunt splenic injury: Using CT to reveal abnormalities of splenic vasculature
128. Management of pediatric blunt splenic injury: Comparison of pediatric and adult trauma surgeons
129. Optimizing the management of blunt splenic injury in adults and children
130. Is early discharge following isolated splenic injury in the hemodynamically stable patient possible?
131. Nonoperative management of the spleen in adults
132. Blunt splenic injuries: Dedicated trauma surgeons can achieve a high rate of nonoperative success in patients of all ages
133. The outcome of current management of splenic injuries
134. Blunt splenic injury in adults: Multi-institutional study of the Eastern Association for the Surgery of Trauma
135. Management of blunt splenic trauma: Significant differences between adults and children
136. Failure of nonoperative management of blunt splenic injury in adults: Multi-institutional study of the Eastern Association for the Surgery of Trauma
137. Experimental study of splenic trauma in monkeys
138. Nonoperative management of splenic injuries: Have we gone too far?
139. Failures of splenic nonoperative management: Is the glass half empty or half full?
140. Zur Kindlichen traumatischen milzruptur
141. Tribute to a triad: History of splenic anatomy, physiology and surgery: Part I
142. Tribute to a triad: History of splenic anatomy, physiology and surgery: Part 2
143. Anatomy of vasculature of 850 spleen specimens and its application in partial splenectomy
144. The spleen: Anatomy and anatomical function
145. Splenic function: Normal, too much and too little
146. Microcirculation of the spleen: An open or closed circulation?
147. Splenectomy: Indications, hazards and alternatives
148. Postsplenectomy leukocytosis: Physiologic or an indicator of infection?
149. Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth
150. Splenic function after nonsurgical management of splenic rupture
151. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy
152. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma
153. Immune consequences of nonoperative treatment of splenic trauma in the rat model
154. Pulmonary antipneumococcal defenses after hemisplenectomy
155. Spleen graft growth in splenectomized mice
156. Limitation of splenic growth as studied by heterotopic splenic implants
157. Regeneration and function of autologous splenic grafts in pigs
158. Splenic autotransplantation: Optimal functional factors
159. Reimmunization and splenic autotransplantation: A long-term study of immunologic response and survival following pneumococcal challenge
160. Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine
161. Lack of protective effect of autotransplanted splenic tissue to pneumococcal challenge
162. Site of splenic autotransplantation affects protection from sepsis
163. Heterotopic splenic autotransplantation in prevention of overwhelming postsplenectomy infection
164. Splenectomy and implantation of splenic tissue
165. Preservation of splenic function by autotransplantation of traumatized spleen in man
166. Posttraumatic autotransplantation of spleen tissue
167. Immune response capacity after human splenic autotransplantation: Restoration of response to individual pneumococcal vaccine subtypes
168. Autologous splenic transplantation for splenic trauma
169. Autotransplantation of splenic tissue
170. Immunization Practices Advisory Committee: Pneumococcal polysaccharide vaccine
171. Immune responses to administration of a vaccine against Haemophilus influenzae type B in splenectomized and non-splenectomized patients
172. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
173. Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages
174. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats
175. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force
176. Immunization against infectious disease
177. Prevention and management of overwhelming post-splenectomy infection-an update
178. Chemoprophylaxis in asplenic adolescents and young adults
179. Asplenic Children
180. Efficacy and safety of pneumococcal revaccination after splenectomy for trauma
181. Pneumococcal vaccination after splenectomy: Survey of hospital and primary care records
182. Patient awareness of health precautions after splenectomy
183. Passive immunization against disease due to Haemophilus influenzae type b: Concentrations of antibody to capsular polysaccharide in high-risk children
184. Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen
185. Failure of vaccination with Haemophilus influenzae vaccine
186. Treatment of pneumococcal infection in the era of increasing penicillin resistance
187. Northern region asplenia register: Analysis of first two years
188. Infections in asplenic adults
189. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial
190. Long term management of patients after splenectomy
191. Do post-splenectomy patients take prophylactic penicillin?
192. Pneumococcal infections in splenectomized children are preventable
193. Asplenic patients' knowledge of prophylactic measures against severe infections
194. Doctor's knowledge of post-splenectomy prophylaxis
195. An algorithm to reduce the incidence of false-negative FAST examinations in patients at high risk for occult injury
196. Abdominal injuries without hemoperitoneum: A potential limitation of focused abdominal sonography for trauma
197. Use of abdominal ultrasonography to assess pediatric splenic trauma: Potential pitfalls in the diagnosis
198. CT of blunt abdominal trauma in adults
199. Organ injury scaling: Spleen and liver
200. Evaluation of splenic injury by computed tomography and its impact on treatment
201. Nonoperative management of adult splenic trauma: Development of computed tomographic scoring system that detects appropriate candidates for expectant management
202. Computed tomography is inaccurate in estimating the severity of adult splenic injury
203. Blunt hepatic and splenic trauma in children: Correlation of a CT injury scale with clinical outcome
204. Splenic injury diagnosed with CT: US follow-up and healing rate in children and adolescents
205. Splenic trauma: Evaluation with CT
206. Splenic trauma: Value of followup CT
207. Nonoperative management of adult blunt splenic trauma: Criteria for successful outcome
208. Computed tomographic grading is useful in the selection of patients for nonoperative management of blunt injury to the spleen
209. Computed tomography-assisted management of splenic trauma
210. Splenic trauma: Is followup CT of value?
211. Nonoperative salvage of computed tomography-diagnosed splenic injuries: Utilization of angiography for triage and embolization for hemostasis
212. Rupture of the spleen. A report of twenty-seven cases
213. Management of splenic injuries
214. Is computer tomographic grading of splenic injury useful in the nonsurgical management of blunt trauma?
215. Selective nonoperative management of liver and spleen injuries in neurologically impaired adult patients
216. Age should not be a consideration for non-operative management of blunt splenic injury
217. Nonoperative management of blunt splenic injury in adults: Age over 55 years as a powerful indicator for failure
218. Contribution of age and gender to outcome of blunt splenic injury in adults: Multicenter study of the Eastern Association for the Surgery of Trauma
219. Nonoperative management of the ruptured spleen: A revalidation of criteria
220. A decision analysis of traumatic splenic injuries
221. Associated head injury should not prevent non-operative management of spleen or liver injury in children
222. Traditional criteria for observation of splenic trauma should be challenged
223. Management of blunt splenic trauma in adults older than 55 years
224. Impact of pediatric trauma centers on mortality in a statewide trauma system
225. Computed tomography grade of splenic injury is predictive of the time required for radiographic healing
226. Comparative study of splenic wound healing in young and adult rats
227. Limited value of routine follow-up CT scans in nonoperative management of blunt liver and splenic injuries
228. Nonoperative management of splenic injury: Are follow-up computed tomographic scans of any value?
229. Evidence-based guidelines for resource utilization in children with isolated spleen or liver injury